TP53 and neoplasm: When we treated GB cells with SLCP or BBR, we observed an increase in levels of p53, indicating anti-tumor activity, whereas co-treatment further upregulated p53 levels, indicating an even stronger effect on this protein (Fig 9A and 9B).